Surgical Science Sweden ABSUSRF -2.20%82 Days Payable is 41.18 as of Mar. 2026, which is 37% below its 10-year median of 64.99. GuruFocus rates SUSRF with a GF Score™ of 82/100 and a GF Value™ of $14.30 (Significantly Undervalued). The stock has 4 warning signs investors should review. Among 608 Healthcare Providers & Services companies, Surgical Science Sweden AB ranks worse than 55.76% on this metric.
The historical rank and industry rank for Surgical Science Sweden AB's Days Payable or its related term are showing as below:
SUSRF'
s Days Payable Range Over the Past 10 Years
Min: 51.27 Med: 64.99 Max: 75.45
Current: 51.27
During the past 11 years, Surgical Science Sweden AB's highest Days Payable was 75.45. The lowest was 51.27. And the median was 64.99.
SUSRF's Days Payable is ranked worse than 55.76% of 608
companies
in the Healthcare Providers & Services industry
Industry Median: 58.08
vs SUSRF: 51.27
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, Surgical Science Sweden AB's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Surgical Science Sweden AB Days Payable vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Surgical Science Sweden AB's Days Payable distribution charts can be found below:
* The bar in red indicates where Surgical Science Sweden AB's Days Payable falls into.
Surgical Science Sweden AB Days Payable Calculation
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Surgical Science Sweden AB (SUSRF) has a Days Payable of 41.18 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Surgical Science Sweden AB and its competitors. This is 37% below median its historical median of 64.99. Over the past decade, Surgical Science Sweden AB's Days Payable has ranged from 51.27 to 75.45. According to the industry distribution chart, Surgical Science Sweden AB ranks #339 out of 608 companies in the Healthcare Providers & Services industry, placing it in the top 55.8%.
Is Surgical Science Sweden AB's Days Payable too high?
Surgical Science Sweden AB's current Days Payable of 41.18 is 37% below median its 10-year median of 64.99. Over the past 10 years, this metric has ranged from a low of 51.27 to a high of 75.45. The Healthcare Providers & Services industry median Days Payable is 58.08. Surgical Science Sweden AB's value of 41.18 is 29.1% below this industry median. Based on the distribution chart, Surgical Science Sweden AB ranks #339 out of 608 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Surgical Science Sweden AB has a GF Score™ of 82/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Surgical Science Sweden AB's Days Payable compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Surgical Science Sweden AB ranks #339 out of 608 companies for Days Payable. This places Surgical Science Sweden AB in the lower half of its industry. The industry median Days Payable is 58.08. Surgical Science Sweden AB's value of 41.18 is 29.1% below this benchmark. Historically, Surgical Science Sweden AB's own Days Payable has ranged from 51.27 to 75.45 over the past decade. While the company's 10-year median is 64.99 vs. the industry median of 58.08, Surgical Science Sweden AB has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Healthcare Providers & Services company?
The median Days Payable among Healthcare Providers & Services companies is 58.08, based on 608 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Surgical Science Sweden AB's current Days Payable of 41.18 is 29.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Surgical Science Sweden AB and its competitors. For the Healthcare Providers & Services industry, the median Days Payable is 58.08 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Surgical Science Sweden AB's current Days Payable is 41.18, which is 37% below median its own 10-year median of 64.99. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Surgical Science Sweden AB stock overvalued right now?
Based on GuruFocus' analysis, Surgical Science Sweden AB (SUSRF) is currently considered Significantly Undervalued. The stock's GF Value™ is $14.30, compared to a current price of $4.00 — trading 72% below its estimated fair value. The current Days Payable is 41.18, which is 37% below median its 10-year median of 64.99 and 29.1% below the Healthcare Providers & Services industry median of 58.08. Surgical Science Sweden AB's overall GF Score™ is 82/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Surgical Science Sweden AB (SUSRF), the current Days Payable is 41.18 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Surgical Science Sweden AB (SUSRF) Overvalued in 2026?
Based on GuruFocus' analysis, Surgical Science Sweden AB stock appears to be undervalued.
The current stock price of $4.00 is trading 72% below its estimated GF Value™ of $14.30.
GuruFocus considers Surgical Science Sweden AB to be Significantly Undervalued.
Key valuation signals for SUSRF:
Days Payable: 41.18 (37% below median its 10-year median of 64.99)
GF Value™: $14.30 vs. price of $4.00 (72% below fair value)
Industry Position: 29.1% below the Healthcare Providers & Services median (#339 of 608)
No single metric tells the full story. See the SUSRF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Surgical Science Sweden AB is a supplier of virtual reality simulators for medical training. The company's core is its proprietary software and hardware for simulating interactions between instruments and anatomy. It has two operating segments: Educational products include Proprietary brand medical simulator hardware and software for generic training of psycho-motor skills, instrument handling, and training for a large number of procedures and examinations prior to entering the clinical environment, as well as support and services. Industry/OEM includes simulation software for product-specific training of surgeons in robot-assisted surgery and other digitalized medical instruments, and also simulators for medical device companies.
82GF Score
Get the complete analysis for SUSRF
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SUSRF has been successfully added to your 
